Oragenics, Inc.OGENNYSE
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q3 2025 | 316.63% |
| Q2 2025 | -128321.76% |
| Q1 2025 | 808.68% |
| Q4 2024 | -106.79% |
| Q3 2024 | 60.98% |
| Q2 2024 | -61.00% |
| Q1 2024 | -38.61% |
| Q4 2023 | -55.64% |
| Q3 2023 | -23.06% |
| Q2 2023 | -29.41% |
| Q1 2023 | -13.71% |
| Q4 2022 | -25.04% |
| Q3 2022 | -9.29% |
| Q2 2022 | -23.64% |
| Q1 2022 | -18.23% |
| Q4 2021 | -5.92% |
| Q3 2021 | -13.09% |
| Q2 2021 | -19.31% |
| Q1 2021 | 41.31% |
| Q4 2020 | 53.37% |
| Q3 2020 | -3.99% |
| Q2 2020 | -39.87% |
| Q1 2020 | -28.20% |
| Q4 2019 | -13.63% |
| Q3 2019 | -14.77% |
| Q2 2019 | -44.45% |
| Q1 2019 | -0.50% |
| Q4 2018 | -18.18% |
| Q3 2018 | 93.38% |
| Q2 2018 | -29.96% |
| Q1 2018 | -32.57% |
| Q4 2017 | 523.59% |
| Q3 2017 | 100.44% |
| Q2 2017 | -57.44% |
| Q1 2017 | -61.89% |
| Q4 2016 | -30.77% |
| Q3 2016 | -30.15% |
| Q2 2016 | 81.80% |
| Q1 2016 | -44.43% |
| Q4 2015 | 213.79% |